Age-Independent Preoperative Chemosensitivity and 5-Year Outcome Determined by Combined 70- and 80-Gene Signature in a Prospective Trial in Early-Stage Breast Cancer

BACKGROUND: The Neoadjuvant Breast Symphony Trial (NBRST) demonstrated the 70-gene risk of distant recurrence signature, MammaPrint, and the 80-gene molecular subtyping signature, BluePrint, precisely determined preoperative pathological complete response (pCR) in breast cancer patients. We report 5...

Descripción completa

Detalles Bibliográficos
Autores principales: Whitworth, Pat, Beitsch, Peter D., Pellicane, James V., Baron, Paul L., Lee, Laura A., Dul, Carrie L., Nash, Charles H., Murray, Mary K., Richards, Paul D., Gittleman, Mark, Budway, Raye, Rahman, Rakhshanda Layeequr, Kelemen, Pond, Dooley, William C., Rock, David T., Cowan, Ken, Lesnikoski, Beth-Ann, Barone, Julie L., Ashikari, Andrew Y., Dupree, Beth, Wang, Shiyu, Menicucci, Andrea R., Yoder, Erin B., Finn, Christine, Corcoran, Kate, Blumencranz, Lisa E., Audeh, William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Breast Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174138/
https://www.ncbi.nlm.nih.gov/pubmed/35378634
http://dx.doi.org/10.1245/s10434-022-11666-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174138/
https://www.ncbi.nlm.nih.gov/pubmed/35378634
http://dx.doi.org/10.1245/s10434-022-11666-2

Ejemplares similares